← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 25, 2020Last known activity
Jan 31, 2025
Timeline
2010s
- Jun 1, 2016
Neuraptive Therapeutics Inc.— Founded
Drugs by trial phase (1 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT05565846Lead sponsorN/A—
- NCT06616025Lead sponsorPhase 3Jan 31, 2025
- NCT06616025OfficialPhase 3Jan 31, 2025
- NCT05293522Lead sponsorPhase 2Jul 12, 2022
- NCT04572906Study chairPhase 2Sep 25, 2020
- NCT04572906Lead sponsorPhase 2Sep 25, 2020
Details
- Founded
- Lafayette, CO, US Jun 1, 2016
- Last known activity
- Jan 31, 2025